(2-(Azetidin-1-yl)pyrimidin-5-yl)boronic acid

Catalog No.: 
ACHRND964
CAS No.: 
1411643-59-8
Molecular Formula: 
C7H10BN3O2
Molecular Weight: 
178.99
(2-(Azetidin-1-yl)pyrimidin-5-yl)boronic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g96%$112.00In stockInquiry
5g96%$429.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2-(Azetidin-1-yl)pyrimidin-5-yl)boronic acid
IUPAC Name(2-(azetidin-1-yl)pyrimidin-5-yl)boronic acid
MDL No.MFCD18261197
Molecular FormulaC7H10BN3O2
Molecular Weight178.99
SMILESOB(C1=CN=C(N2CCC2)N=C1)O
InChI KeyNQBHKXVNPWRYKQ-UHFFFAOYSA-N
Synonym(2-(Azetidin-1-yl)pyriMidin-5-yl)boronic acid;Boronic acid, B-[2-(1-azetidinyl)-5-pyrimidinyl]-
CAS No.1411643-59-8
PubChem CID60150325

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACHRND964 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOQLA591 route compound structure diagram
    ACOQLA59136520-39-5In Stock
  2. Plus
  3. ACONSD781 route compound structure diagram
    ACONSD7811003845-06-4In Stock
  4. Then
  5. ACHRND964 route product structure diagram
    ACHRND9641411643-59-8In Stock
Inquiry

2. ACHRND964 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOQLA591 route compound structure diagram
    ACOQLA59136520-39-5In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHRND964 route product structure diagram
    ACHRND9641411643-59-8In Stock
Inquiry

3. ACHRND964 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHRND964 route product structure diagram
    ACHRND9641411643-59-8In Stock
Inquiry

Comments (0)